Arthur B. Page’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $726K | Sell |
7,505
-9,839
| -57% | -$1.01M | 0.75% | 33 |
|
|
2023
Q4 | $1.75M | Sell |
17,344
-5,280
| -23% | -$510K | 1.85% | 25 |
|
|
2023
Q3 | $2.3M | Sell |
22,624
-2,023
| -8% | -$205K | 2.39% | 22 |
|
|
2023
Q2 | $2.49M | Sell |
24,647
-1,919
| -7% | -$192K | 2.36% | 19 |
|
|
2023
Q1 | $2.44M | Buy |
26,566
+170
| +0.6% | +$14.8K | 2.29% | 20 |
|
|
2022
Q4 | $2.39M | Buy |
26,396
+198
| +0.8% | +$16.7K | 2.35% | 20 |
|
|
2022
Q3 | $1.99M | Sell |
26,198
-650
| -2% | -$53.9K | 2.08% | 22 |
|
|
2022
Q2 | $2.27M | Sell |
26,848
-968
| -3% | -$84.9K | 2.15% | 19 |
|
|
2022
Q1 | $2.44M | Buy |
27,816
+12
| +0% | +$1.04K | 1.9% | 22 |
|
|
2021
Q4 | $2.43M | Sell |
27,804
-4,272
| -13% | -$355K | 1.67% | 27 |
|
|
2021
Q3 | $2.62M | Sell |
32,076
-865
| -3% | -$77.8K | 1.95% | 24 |
|
|
2021
Q2 | $3.01M | Sell |
32,941
-905
| -3% | -$80.6K | 2.14% | 21 |
|
|
2021
Q1 | $2.89M | Sell |
33,846
-2,277
| -6% | -$204K | 2.16% | 21 |
|
|
2020
Q4 | $3.41M | Buy |
36,123
+325
| +0.9% | +$28.4K | 2.58% | 20 |
|
|
2020
Q3 | $3.11M | Sell |
35,798
-30
| -0.1% | -$2.6K | 2.58% | 17 |
|
|
2020
Q2 | $3.13M | Sell |
35,828
-2,506
| -7% | -$216K | 2.76% | 13 |
|
|
2020
Q1 | $3.16M | Buy |
38,334
+348
| +0.9% | +$31K | 3.14% | 11 |
|
|
2019
Q4 | $3.6M | Sell |
37,986
-1,095
| -3% | -$98.3K | 2.9% | 12 |
|
|
2019
Q3 | $3.4M | Sell |
39,081
-3,120
| -7% | -$280K | 2.85% | 16 |
|
|
2019
Q2 | $3.85M | Sell |
42,201
-4,962
| -11% | -$420K | 3.15% | 12 |
|
|
2019
Q1 | $4.06M | Sell |
47,163
-34
| -0.1% | -$2.73K | 3.39% | 9 |
|
|
2018
Q4 | $3.63M | Sell |
47,197
-189
| -0.4% | -$14.7K | 3.51% | 8 |
|
|
2018
Q3 | $3.66M | Buy |
47,386
+72
| +0.2% | +$5.32K | 3.09% | 13 |
|
|
2018
Q2 | $3.2M | Sell |
47,314
-393
| -0.8% | -$27.1K | 2.92% | 14 |
|
|
2018
Q1 | $3.46M | Buy |
47,707
+6
| +0% | +$457 | 3.13% | 13 |
|
|
2017
Q4 | $3.59M | Sell |
47,701
-163
| -0.3% | -$12.3K | 3.12% | 11 |
|
|
2017
Q3 | $3.68M | Sell |
47,864
-692
| -1% | -$52.3K | 3.24% | 10 |
|
|
2017
Q2 | $3.63M | Sell |
48,556
-67
| -0.1% | -$4.75K | 3.17% | 10 |
|
|
2017
Q1 | $3.23M | Sell |
48,623
-865
| -2% | -$57.6K | 2.88% | 14 |
|
|
2016
Q4 | $3.23M | Buy |
49,488
+988
| +2% | +$64.1K | 3.09% | 10 |
|
|
2016
Q3 | $3.43M | Buy |
48,500
+580
| +1% | +$42.3K | 3.37% | 6 |
|
|
2016
Q2 | $3.54M | Buy |
47,920
+1,010
| +2% | +$69.8K | 3.56% | 5 |
|
|
2016
Q1 | $3.05M | Sell |
46,910
-435
| -0.9% | -$29.6K | 3.11% | 9 |
|
|
2015
Q4 | $3.65M | Buy |
47,345
+178
| +0.4% | +$14.1K | 3.74% | 6 |
|
|
2015
Q3 | $3.88M | Sell |
47,167
-1,367
| -3% | -$122K | 4.12% | 4 |
|
|
2015
Q2 | $4.28M | Sell |
48,534
-150
| -0.3% | -$13.8K | 4% | 3 |
|
|
2015
Q1 | $4.3M | Sell |
48,684
-475
| -1% | -$42.1K | 4.09% | 3 |
|
|
2014
Q4 | $4.08M | Buy |
49,159
+274
| +0.6% | +$22.7K | 3.88% | 5 |
|
|
2014
Q3 | $4.12M | Buy |
48,885
+1,250
| +3% | +$101K | 4.07% | 3 |
|
|
2014
Q2 | $3.86M | Buy |
47,635
+307
| +0.6% | +$24.1K | 3.61% | 4 |
|
|
2014
Q1 | $3.6M | Buy |
47,328
+669
| +1% | +$48.7K | 3.47% | 3 |
|
|
2013
Q4 | $3.36M | Buy |
+46,659
| New | +$3.24M | 3.39% | 4 |
|
Other funds holding NVS
Arthur B. Page's NVS Position: Q1 2024 in Review
Arthur B. Page reduced its Novartis (NVS) stake by 57% in Q1 2024, selling an estimated $1.01M and leaving 7,505 shares worth $726K. The position accounts for 0.75% of the portfolio, ranked #33.
Arthur B. Page first reported a position in NVS in Q4 2013 and has held it in 42 quarters since. The position peaked at $4.3M in Q1 2015. 1,254 funds tracked by Wall St. Rank hold NVS as of Q1 2024.
- Arthur B. Page held 7,505 shares of Novartis worth $726K as of Q1 2024.
- Arthur B. Page sold 9,839 Novartis shares in Q1 2024, an estimated $1.01M.
- Novartis made up 0.75% of Arthur B. Page's portfolio in Q1 2024, its #33 holding.
- Arthur B. Page first reported a position in Novartis in Q4 2013 and has held it in 42 quarters since.
- Arthur B. Page's Novartis position peaked at $4.3M in Q1 2015.
- 1,254 funds tracked by Wall St. Rank held Novartis as of Q1 2024.
Based on Arthur B. Page's 13F filing for Q1 2024, filed 29 Apr 2024.